Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K F Bhattacharya

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2000
Primary anticholinergic-responsive Pisa syndromeK F Bhattacharya, I Giannakikou, N Munroe, et al.
Neurology|November 27, 2002
Stimulation of the subthalamic nucleus increases heart rate in patients with Parkinson diseaseH Kaufmann, K F Bhattacharya, A Voustianiouk, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 23, 2001
A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapyS Pal, K F Bhattacharya, C Agapito, et al.
Parkinsonism & Related Disorders|March 6, 2003
Selegiline in the treatment of Parkinson's disease: its impact on orthostatic hypotensionK F Bhattacharya, S Nouri, C W Olanow, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2000
Primary anticholinergic-responsive Pisa syndromeK F Bhattacharya, I Giannakikou, N Munroe, et al.
Neurology|November 27, 2002
Stimulation of the subthalamic nucleus increases heart rate in patients with Parkinson diseaseH Kaufmann, K F Bhattacharya, A Voustianiouk, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 23, 2001
A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapyS Pal, K F Bhattacharya, C Agapito, et al.
Parkinsonism & Related Disorders|March 6, 2003
Selegiline in the treatment of Parkinson's disease: its impact on orthostatic hypotensionK F Bhattacharya, S Nouri, C W Olanow, et al.
Pageof 1